Long-Term Exposure of Early-Transformed Human Mammary Cells to Low Doses of Benzo[a]pyrene and/or Bisphenol A Enhances Their Cancerous Phenotype via an AhR/GPR30 Interplay.
AhR
Benzo[a]pyrene
Bisphenol-A
GPR30
breast cancer
environmental factors
tumor progression
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2020
2020
Historique:
received:
29
11
2019
accepted:
15
04
2020
entrez:
17
7
2020
pubmed:
17
7
2020
medline:
17
7
2020
Statut:
epublish
Résumé
It is of utmost importance to decipher the role of chronic exposure to low doses of environmental carcinogens on breast cancer progression. The early-transformed triple-negative human mammary MCF10AT1 cells were chronically (60 days) exposed to low doses (10
Identifiants
pubmed: 32670863
doi: 10.3389/fonc.2020.00712
pmc: PMC7326103
doi:
Types de publication
Journal Article
Langues
eng
Pagination
712Informations de copyright
Copyright © 2020 Donini, El Helou, Wierinckx, Győrffy, Aires, Escande, Croze, Clezardin, Lachuer, Diab-Assaf, Ghayad, Fervers, Cavaillès, Maguer-Satta and Cohen.
Références
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt F):9-562
pubmed: 23189753
PLoS One. 2014 Jan 03;9(1):e81126
pubmed: 24404125
Carcinogenesis. 1993 Mar;14(3):483-92
pubmed: 8453725
Am J Pathol. 1996 Jan;148(1):313-9
pubmed: 8546221
Mol Oncol. 2014 Dec;8(8):1441-57
pubmed: 24973012
Nat Chem Biol. 2006 Apr;2(4):207-12
pubmed: 16520733
Mol Pharmacol. 2002 Oct;62(4):806-16
pubmed: 12237327
Cell Death Dis. 2014 Jan 30;5:e1038
pubmed: 24481452
BMC Biol. 2016 Mar 16;14:20
pubmed: 26984638
J Steroid Biochem Mol Biol. 2012 Apr;129(3-5):191-200
pubmed: 21729753
Expert Opin Drug Metab Toxicol. 2019 Mar;15(3):219-229
pubmed: 30644759
PLoS One. 2014 Nov 05;9(11):e108698
pubmed: 25372613
Pathobiology. 2008;75(2):75-84
pubmed: 18544962
Mol Endocrinol. 2000 Oct;14(10):1649-60
pubmed: 11043579
Int J Clin Exp Pathol. 2014 Oct 15;7(11):7931-7
pubmed: 25550834
Environ Health Perspect. 2010 Aug;118(8):1055-70
pubmed: 20338858
J Exp Clin Cancer Res. 2019 Aug 1;38(1):335
pubmed: 31370872
Carcinogenesis. 2009 Nov;30(11):1957-61
pubmed: 19755658
Int J Mol Sci. 2019 Feb 26;20(5):
pubmed: 30813617
Bull Environ Contam Toxicol. 1981 Jul;27(1):23-7
pubmed: 7296033
Eur J Cancer. 2000 Jun;36(10):1275-82
pubmed: 10882866
Cancer Res. 2008 Feb 15;68(4):989-97
pubmed: 18281472
Cancer Res. 1999 Feb 1;59(3):590-6
pubmed: 9973205
PLoS One. 2010 Feb 15;5(2):e9201
pubmed: 20169162
Ann Oncol. 2013 Sep;24(9):2206-23
pubmed: 23917950
Int J Mol Sci. 2019 Jan 14;20(2):
pubmed: 30646517
Stem Cell Rev. 2007 Jun;3(2):169-75
pubmed: 17873349
Mutat Res. 2001 Jan 25;473(1):85-99
pubmed: 11166028
Pharmacol Rep. 2015 Oct;67(5):996-1009
pubmed: 26398396
Mutat Res. 2017 Oct;774:12-24
pubmed: 29173495
Carcinogenesis. 2000 Mar;21(3):345-51
pubmed: 10688854
Cancer Biol Ther. 2007 Mar;6(3):308-12
pubmed: 17387266
PLoS One. 2016 May 03;11(5):e0154629
pubmed: 27138278
Horm Cancer. 2014 Feb;5(1):11-21
pubmed: 24078229
Environ Health Perspect. 2002 Feb;110 Suppl 1:119-28
pubmed: 11834470
J Adv Res. 2018 Dec 08;16:75-86
pubmed: 30899591
Mutagenesis. 2014 Nov;29(6):409-17
pubmed: 25245543
Chem Rev. 2011 Apr 13;111(4):2507-36
pubmed: 21265518
J Pharmacol Exp Ther. 2011 Jul;338(1):318-27
pubmed: 21493753
Cancer Res. 1990 Sep 15;50(18):6075-86
pubmed: 1975513
Stem Cell Reports. 2015 Feb 10;4(2):239-54
pubmed: 25601208
Mol Carcinog. 2008 May;47(5):338-48
pubmed: 17932946
Vitam Horm. 2014;94:229-51
pubmed: 24388193
Neoplasia. 2013 Apr;15(4):454-60
pubmed: 23555190
Carcinogenesis. 2002 Jul;23(7):1171-6
pubmed: 12117775
Toxicol Pathol. 2010 Jan;38(1):110-22
pubmed: 19933552
J Clin Oncol. 2008 Jun 10;26(17):2813-20
pubmed: 18539959
J Mammary Gland Biol Neoplasia. 2000 Oct;5(4):379-91
pubmed: 14973383
EMBO J. 2009 Mar 4;28(5):523-32
pubmed: 19153601
Toxicol Lett. 2018 Jun 1;289:54-62
pubmed: 29545172
Toxicol Lett. 2015 May 5;234(3):201-10
pubmed: 25724548
PLoS One. 2018 Jan 10;13(1):e0190619
pubmed: 29320557
Cancer Lett. 2005 Apr 28;221(2):213-24
pubmed: 15808407
Mol Cancer. 2017 Jan 19;16(1):14
pubmed: 28103884
Mol Cancer. 2010 Nov 08;9:291
pubmed: 21059223
Mol Pharmacol. 2016 Nov;90(5):674-688
pubmed: 27573671
Mol Pharmacol. 2007 Sep;72(3):572-81
pubmed: 17573484
Breast Cancer Res Treat. 2000 Sep;63(2):117-31
pubmed: 11097088
Cancer Lett. 2013 Jun 1;333(1):113-23
pubmed: 23352646
Cancer Cell. 2006 Dec;10(6):515-27
pubmed: 17157791
Cancer Res. 2012 Jul 15;72(14):3593-606
pubmed: 22593193
BMC Cancer. 2015 Dec 29;15:1026
pubmed: 26715507
Reprod Toxicol. 2007 Aug-Sep;24(2):178-98
pubmed: 17628395
Nat Chem Biol. 2009 Jun;5(6):421-7
pubmed: 19430488
Carcinogenesis. 2000 Jul;21(7):1281-9
pubmed: 10874004
Neoplasia. 2008 Apr;10(4):314-29
pubmed: 18392133
Environ Health Perspect. 2011 Aug;119(8):1053-61
pubmed: 21697028
Toxicol Appl Pharmacol. 2015 Oct 15;288(2):131-42
pubmed: 25620055
Breast Cancer Res Treat. 2012 Apr;132(3):1025-34
pubmed: 21773767
Front Endocrinol (Lausanne). 2014 May 06;5:66
pubmed: 24834064
Genes Dev. 2003 May 15;17(10):1253-70
pubmed: 12756227
Breast Cancer Res Treat. 2013 Jul;140(2):219-32
pubmed: 23836010
Environ Mol Mutagen. 2002;39(2-3):254-63
pubmed: 11921196
J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):175-9
pubmed: 17088055
Environ Int. 2019 Nov;132:105028
pubmed: 31382183
PLoS One. 2012;7(10):e45767
pubmed: 23056216
Arch Toxicol. 2016 Aug;90(8):1939-48
pubmed: 26475489
Mol Carcinog. 2012 Mar;51(3):280-9
pubmed: 21882252
Environ Res. 2016 Nov;151:251-264
pubmed: 27504873
Reprod Toxicol. 2016 Jan;59:167-82
pubmed: 26493093
Cell Death Differ. 2017 Jan;24(1):155-166
pubmed: 27740625
Environ Mol Mutagen. 2002;39(2-3):119-26
pubmed: 11921179